Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden
Crossref DOI link: https://doi.org/10.1007/s13300-014-0080-0
Published Online: 2014-09-12
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kiadaliri, Aliasghar A.
Gerdtham, Ulf G.
Eliasson, Bjorn
Carlsson, Katarina Steen
Text and Data Mining valid from 2014-09-12
Article History
Received: 28 July 2014
First Online: 12 September 2014